Literature DB >> 29341312

Recurrent terbinafine resistant Trichophyton rubrum infection in a child with congenital ichthyosis.

Louise Schøsler1, Louise Kronborg Andersen1, Maiken Cavling Arendrup2,3,4, Mette Sommerlund1.   

Abstract

Dermatophytosis in children caused by Trichophyton rubrum is preferably treated with topical or systemic terbinafine. We report the first case of terbinafine resistance in a child with recurrent T. rubrum dermatophytosis and congenital ichthyosiform erythroderma.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  antifungal treatment; dermatophytosis; ichthyosis; resistance

Mesh：

Substances：

Year:  2018        PMID： 29341312     DOI： 10.1111/pde.13411

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN： 0736-8046            Impact factor:   1.588


  14 in total

1.  The Growing Problem of Antifungal Resistance in Onychomycosis and Other Superficial Mycoses.

Authors:  Aditya K Gupta; Helen J Renaud; Emma M Quinlan; Neil H Shear; Vincent Piguet
Journal:  Am J Clin Dermatol       Date:  2020-12-22       Impact factor: 7.403

2.  In Vitro Resistance and Evolution of Resistance to Tavaborole in Trichophyton rubrum.

Authors:  Diletta Mazzantini; Francesco Celandroni; Marco Calvigioni; Antonella Lupetti; Emilia Ghelardi
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.191

3.  Gene Amplification of CYP51B: a New Mechanism of Resistance to Azole Compounds in Trichophyton indotineae.

Authors:  Tsuyoshi Yamada; Takashi Yaguchi; Mari Maeda; Mohamed Mahdi Alshahni; Karine Salamin; Emmanuella Guenova; Marc Feuermann; Michel Monod
Journal:  Antimicrob Agents Chemother       Date:  2022-05-12       Impact factor: 5.938

4.  Correlation of In Vitro Susceptibility Based on MICs and Squalene Epoxidase Mutations with Clinical Response to Terbinafine in Patients with Tinea Corporis/Cruris.

Authors:  Ananta Khurana; Aradhana Masih; Anuradha Chowdhary; Kabir Sardana; Sagar Borker; Aastha Gupta; R K Gautam; P K Sharma; Dhruv Jain
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

5.  Emerging Terbinafine Resistance in Trichophyton: Clinical Characteristics, Squalene Epoxidase Gene Mutations, and a Reliable EUCAST Method for Detection.

Authors:  Ditte M L Saunte; Rasmus K Hare; Karin M Jørgensen; René Jørgensen; Mette Deleuran; Claus O Zachariae; Simon F Thomsen; Lars Bjørnskov-Halkier; Kristian Kofoed; Maiken C Arendrup
Journal:  Antimicrob Agents Chemother       Date:  2019-09-23       Impact factor: 5.191

6.  Clinical Implications of Antifungal Drug Susceptibility Testing of Dermatophytes.

Authors:  Ananta Khurana; Kabir Sardana; Anuradha Chowdhary; Khushboo Sethia
Journal:  Indian Dermatol Online J       Date:  2019-11-01

7.  Molecular Epidemiology and Antifungal Susceptibility of Trichophyton Isolates in Greece: Emergence of Terbinafine-Resistant Trichophytonmentagrophytes Type VIII Locally and Globally.

Authors:  Maria Siopi; Ioanna Efstathiou; Konstantinos Theodoropoulos; Spyros Pournaras; Joseph Meletiadis
Journal:  J Fungi (Basel)       Date:  2021-05-27

8.  Terbinafine Resistance in Dermatophytes: A French Multicenter Prospective Study.

Authors:  Alicia Moreno-Sabater; Anne-Cécile Normand; Anne-Laure Bidaud; Geneviève Cremer; Françoise Foulet; Sophie Brun; Christine Bonnal; Nawel Aït-Ammar; Arnaud Jabet; Aymen Ayachi; Renaud Piarroux; Françoise Botterel; Sandrine Houzé; Guillaume Desoubeaux; Christophe Hennequin; Eric Dannaoui
Journal:  J Fungi (Basel)       Date:  2022-02-23

9.  Congenital ichthyosis associated with Trichophyton rubrum tinea, imitating drug hypersensitivity reaction.

Authors:  Eszter Szlávicz; Csongor Németh; Éva Szepes; Csaba Gyömörei; Rolland Gyulai; Zsuzsanna Lengyel
Journal:  Med Mycol Case Rep       Date:  2020-05-29

10.  Trichophyton rubrum Azole Resistance Mediated by a New ABC Transporter, TruMDR3.

Authors:  Michel Monod; Marc Feuermann; Karine Salamin; Marina Fratti; Maya Makino; Mohamed Mahdi Alshahni; Koichi Makimura; Tsuyoshi Yamada
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.